Semaglutide vs. Tirzepatide: How to Compare Your Options
If you’re seeking prescription medications to help with weight loss, you may be trying to decide whether semaglutide (Wegovy®) or tirzepatide (Zepbound®) may be the better option for you.
Editorial guides, provider comparisons, and treatment insights to help you research care options.
Showing posts in Medication Insights. Evidence-based analysis of medications and dosing protocols
If you’re seeking prescription medications to help with weight loss, you may be trying to decide whether semaglutide (Wegovy®) or tirzepatide (Zepbound®) may be the better option for you.
If you’re being offered semaglutide "the same as Ozempic," it’s important to understand the distinctions. Ozempic is an FDA-approved semaglutide drug. Compounded semaglutide is not FDA-approved, does not inherit Ozempic’s clinical trial evidence, and isn’t Ozempic’s generic.
Phase 2 data show roughly 24% mean weight loss at 48 weeks with retatrutide. With Phase 3 and an outcomes trial underway, here is how a triple agonist could reset the GLP-1 era.